Search

Your search keyword '"recurrence vertigo"' showing total 3 results
Start Over Descriptor "recurrence vertigo"
3 results on '"recurrence vertigo"'

1. Benign paroxysmal positional vertigo: is hypothyroidism a risk factor for recurrence?

Author

Tricarico, Laura, Di Cesare, Tiziana, Galli, Jacopo, Fetoni, Anna Rita, Paludetti, Gaetano, Picciotti, Pasqualina Maria, Galli, Jacopo (ORCID:0000-0001-6353-6249), Fetoni, Anna Rita (ORCID:0000-0001-5405-4301), Paludetti, Gaetano (ORCID:0000-0003-2480-1243), Picciotti, Pasqualina Maria (ORCID:0000-0002-1502-6508), Tricarico, Laura, Di Cesare, Tiziana, Galli, Jacopo, Fetoni, Anna Rita, Paludetti, Gaetano, Picciotti, Pasqualina Maria, Galli, Jacopo (ORCID:0000-0001-6353-6249), Fetoni, Anna Rita (ORCID:0000-0001-5405-4301), Paludetti, Gaetano (ORCID:0000-0003-2480-1243), and Picciotti, Pasqualina Maria (ORCID:0000-0002-1502-6508)

Abstract

Objective: To investigate the relationship between risk of Benign Paroxysmal Positional Vertigo (BPPV) recurrence and hypothyroidism treated with hormone replacement therapy (HRT). Methods: 797 patients with idiopathic BPPV were divided into two groups: 250 patients with recurrence of BPPV (R-BPPV) and 547 patients without recurrence (NR-BPPV). Regarding patients with thyroid disease on HRT, we collected serum test results of thyroidstimulating hormone (TSH), free triiodothyronine f-T3, free thyroxine f-T4, thyroglobulin antibodies (TG-Ab) and thyroid peroxidase antibodies (TPO-Ab). Results: Hypothyroidism in long-term HRT was found in 61/250 (24.4%) patients of the RBPPV group vs 79/547 (14.4%) of the NR-BPPV-group (p = 0.0006). Hashimoto thyroiditis (HT) was associated with recurrence (p < 0.0001). A significant correlation was found between recurrence and level of serum TPO-Ab (p = 0.0117) and TG-Ab (p = 0.0025), but not with mean serum TSH, f-T3 and f-T4. Conclusions: We assume that patients with hypothyroidism in HRT have an increased risk of BPPV recurrence, which is particularly strong for patients with HT and positive thyroid antibodies, suggesting an association between autoimmunity and recurrent vertigo.

Published
2022

2. Benign paroxysmal positional vertigo: is hypothyroidism a risk factor for recurrence?

Author

Laura Tricarico, Tiziana Di Cesare, Jacopo Galli, Anna Rita Fetoni, Gaetano Paludetti, and Pasqualina Maria Picciotti

Subjects
vertigo Comorbidities, General Energy, Otorhinolaryngology, thyroid autoimmunity, recurrence vertigo, hypothyroidism, Settore MED/31 - OTORINOLARINGOIATRIA, BPPV
Abstract

To investigate the relationship between risk of Benign Paroxysmal Positional Vertigo (BPPV) recurrence and hypothyroidism treated with hormone replacement therapy (HRT).797 patients with idiopathic BPPV were divided into two groups: 250 patients with recurrence of BPPV (R-BPPV) and 547 patients without recurrence (NR-BPPV). Regarding patients with thyroid disease on HRT, we collected serum test results of thyroidstimulating hormone (TSH), free triiodothyronine f-T3, free thyroxine f-T4, thyroglobulin antibodies (TG-Ab) and thyroid peroxidase antibodies (TPO-Ab).Hypothyroidism in long-term HRT was found in 61/250 (24.4%) patients of the RBPPV group vs 79/547 (14.4%) of the NR-BPPV-group (p = 0.0006). Hashimoto thyroiditis (HT) was associated with recurrence (p0.0001). A significant correlation was found between recurrence and level of serum TPO-Ab (p = 0.0117) and TG-Ab (p = 0.0025), but not with mean serum TSH, f-T3 and f-T4.We assume that patients with hypothyroidism in HRT have an increased risk of BPPV recurrence, which is particularly strong for patients with HT and positive thyroid antibodies, suggesting an association between autoimmunity and recurrent vertigo.Vertigine parossistica posizionale benigna: l’ipotiroidismo è un fattore di rischio per la ricorrenza?Analisi dell’associazione tra la ricorrenza della Vertigine parossistica posizionale benigna (BPPV) e l’ipotiroidismo in corso di terapia ormonale sostitutiva (TOS).797 pazienti affetti da BPPV idiopatica sono stati suddivisi in due gruppi: 250 con vertigine ricorrente (R-BPPV) e 547 (NR-BPPV) non ricorrente. Nei pazienti ipotiroidei sono stati analizzati i valori ematici tiroidei: ormone tireotropo (TSH), frazioni libere di tetraiodotironina (f-T4) e triiodiotironina (f-T3), anticorpi anti tireoperossidasi (TPO-Ab) ed anti tireoglobulina (TG-Ab).L’ipotiroidismo è emerso in 61/250 (24,4%) pazienti del gruppo R-BPPV vs 79/547 (14,4%) del gruppo NR - BPPV (p = 0,0006). La ricorrenza è risultata statisticamente associata alla tiroidite di Hashimoto (HT) (p0,0001) ed alla positività anticorpale di Ab-TPO (p = 0,0117) e Ab-TG (p = 0,0025); le concentrazioni sieriche medie di TSH, f-T3 e f-T4 non sono risultate statisticamente significative.nei pazienti affetti da ipotiroidismo in TOS è stato dimostrato un aumentato rischio di ricorrenza di BPPV, particolarmente evidente nei pazienti con HT e dosaggio anticorpale tiroideo positivo, suggerendo l’associazione tra autoimmunità e ricorrenza della vertigine.

Published
2021

3. Benign paroxysmal positional vertigo: is hypothyroidism a risk factor for recurrence?

Author

Tricarico L, Di Cesare T, Galli J, Fetoni AR, Paludetti G, and Picciotti PM

Subjects
Humans, Benign Paroxysmal Positional Vertigo complications, Risk Factors, Thyrotropin, Recurrence, Hypothyroidism complications, Hashimoto Disease complications
Abstract

Objective: To investigate the relationship between risk of Benign Paroxysmal Positional Vertigo (BPPV) recurrence and hypothyroidism treated with hormone replacement therapy (HRT)., Methods: 797 patients with idiopathic BPPV were divided into two groups: 250 patients with recurrence of BPPV (R-BPPV) and 547 patients without recurrence (NR-BPPV). Regarding patients with thyroid disease on HRT, we collected serum test results of thyroid-stimulating hormone (TSH), free triiodothyronine f-T3, free thyroxine f-T4, thyroglobulin antibodies (TG-Ab) and thyroid peroxidase antibodies (TPO-Ab)., Results: Hypothyroidism in long-term HRT was found in 61/250 (24.4%) patients of the R-BPPV group vs 79/547 (14.4%) of the NR-BPPV-group (p = 0.0006). Hashimoto thyroiditis (HT) was associated with recurrence (p < 0.0001). A significant correlation was found between recurrence and level of serum TPO-Ab (p = 0.0117) and TG-Ab (p = 0.0025), but not with mean serum TSH, f-T3 and f-T4., Conclusions: We assume that patients with hypothyroidism in HRT have an increased risk of BPPV recurrence, which is particularly strong for patients with HT and positive thyroid antibodies, suggesting an association between autoimmunity and recurrent vertigo., (Copyright © 2022 Società Italiana di Otorinolaringoiatria e Chirurgia Cervico-Facciale, Rome, Italy.)

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results